781/1272US=3 / Ortopedia
Morgan HD. Askin's tumor of the chest wall. In: Conrad III EU. Orthopaedic oncology: diagnosis and treatment. New York: Thieme, 2009. p. 291-4. ISBN 978-1-58890-523-9.

TUMOR DE ASKIN; PAREDE TORACICA


782/1272US=3 / Ortopedia
Conrad III EU. Gluteal pleomorphic spindle cell sarcoma (NOS) of the pelvis. In: ___. Orthopaedic oncology: diagnosis and treatment. New York: Thieme, 2009. p. 295-7. ISBN 978-1-58890-523-9.

GLUTEA PLEOMORFICO; PELVE; SARCOMAS DE CELULAS FUSIFORMES


783/1272US=3 / Ortopedia
Patt JC. Leiomyosarcoma of the pelvis. In: Conrad III EU. Orthopaedic oncology: diagnosis and treatment. New York: Thieme, 2009. p. 298-301. ISBN 978-1-58890-523-9.

LEIOMIOSSARCOMA DA PELVE


784/1272US=3 / Ortopedia
Conrad III EU. Liposarcoma of the retroperitoneum. In: ___. Orthopaedic oncology: diagnosis and treatment. New York: Thieme, 2009. p. 302-4. ISBN 978-1-58890-523-9.

LIPOSSARCOMA DO RETROPERITONIO


785/1272US=59 / Cab/Pesc
Hermans R. Post-treatment imaging. In: ___. Squamous cell cancer of the neck. New York: Cambridge University Press, 2008. p. 135-50. (Contemporary Issues in Cancer Imaging) ISBN 978-0-521-88691-8.

CANCER DE CABECA E PESCOCO; CARCINOMA DE CELULAS ESCAMOSAS; IMAGEM POS-TRATAMENTO


786/1272US=6 / Imagem
Nuyts S. Use of imaging data in radiotherapy planning of head and neck cancer: improved tumour characterization, delineation and treatment verification. In: Hermans R. Head and neck cancer imaging. New York: Springer - Verlag, 2008. p. 345-59. (Medical Radiology Diagnostic Imaging and Radiation Oncology) ISBN 978-3-540-68439-8.

CANCER DE CABECA E PESCOCO; IMAGEM; RADIOTERAPIA


787/1272US=60 / Enfermagem
Colbourne L. The experience of treatment. In: Corner J, Bailey C. Cancer nursing: care in context. 2nd ed. St. Louis: Blackwell Science, 2008. p. 197-217. ISBN 978-1-4051-2253-5.

CANCER. TRATAMENTO


788/1272US=44 / Gastro
Das A, Chak A. Esophageal adenocarcinoma: treatment. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 51. ISBN 978-1-4051-2783-7.

ESOFAGO DE BARRETT. TERAPIA


789/1272US=64 / Câncer
Ailawadhi S, Chanan-Khan A. Current role of anthracyclines in the treatment of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 113-21. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TRATAMENTO DO MIELOMA MULTIPLO. ANTRACICLINAS; ANTRACICLINAS


790/1272US=64 / Câncer
Richardson PG, Mitsiades CS, Schlossman R, Hideshima T, Ghobrial I, Munshi NC, Anderson KC. The role of bortezomib in the treatment of relapsed and refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 239-52. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BORTEZOMIB; MIELOMA MULTIPLO REFRACTARIO. TRATAMENTO


791/1272US=64 / Câncer
Narayanan S, Tong FC. Percutaneous vertebroplasty and balloon kyphoplasty for the treatment of acute painful pathologic fracture. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 469-89. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

VERTEBROPLASTIA PERCUTANEA; CIFOPLASTIA; TRATAMENTO DE FRATURA DOLOROSA


792/1272US=67 / Biol/Mol
Vogl DT, Gewirtz AM. Nucleic acid therapies for cancer treatment. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 413-29. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4.

CANCER. TERAPIA; ACIDO NUCLEICO; OLIGONUCLEOTIDEOS ANTISENSE; DNA; RNAI


793/1272US=67 / Biol/Mol
Bertagnolli M, Viner JL, Hawk ET. Cyclooxygenase-2 as a target for cancer prevention and treatment. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 509-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4.

CICLOOXIGENASE-2; COX-2; CANCER. PREVENCAO; CANCER. TRATAMENTO; INFLAMACAO; PROSTAGLANDINA; TUMORIGENESE


794/1272US=67 / Biol/Mol
Mendelsohn J. Development of a targeted treatment for cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 559-71. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4.

CANCER; TERAPIA; FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; CETUXIMABE; TIROSINA QUINASE; ANTICORPO MONOCLONAL C225


795/1272US=67 / Biol/Mol
Kitzen JJEM, de Jonge MJA, Verweij J. How to define treatment sucess or failure if tumors do not shrink: consequences for trial design. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 657-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4.

MARCADOR SUBSTITUTO; TECIDO SUBSTITUTO; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDOR DA FARNESIL TRANSFERASE; SELECAO DE PACIENTE; IMAGEM; PROJETO DESCONTINUACAO RANDOMIZADO; INDICE DE MODULACAO DO CRESCIMENTO; TAXA DE PROGRESSAO; TAXA LIVRE DE PROGRESSAO


796/1272US=67 / Imagem
Dziadziuszko R, Hirsch FR, Bunn Junior PA. Advances in lung cancer treatment. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 17-37. ISBN 978-0-470-11880-1.

CANCER DE PULMAO; TERAPIA; CARCINOMA DE PULMAO DE NAO-PEQUENAS CELULAS; TRATAMENTO PALIATIVO; CARCINOMA DE PULMAO DE PEQUENAS CELULAS


797/1272US=58 / Câncer
Le XF, Bast Junior RC. p27Kip1 as a biomark and target for treatment of cancer. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 215-33. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6.

P27KIP1; CICLO CELULAR; SUPRESSOR DE TUMOR; TERAPIA ALVO; TRASTUZUMAB


798/1272US=71 / Enfermagem
McIntyre SJ. The sequelae of cancer and its treatment. In: Lockwood S. Contemporary issues in women's cancers. London: Jones & Bartlett Publishers, 2008. p. 245-78. ISBN 978-0-7637-2602-7.

SEQUELAS DE CANCER E SEU TRATAMENTO; NEUROPATIA PERIFERICA; DISFUNCAO DO TRACTO URINARIO; LINFEDEMA; OSTEOPOROSE; FADIGA


799/1272US=84-A / Biol/Mol
Rane SG, Lin HM, Lee JH. Transformig growth factor-B in developing and advanced cancers: transforming growth factor-B signaling in pancreas development and pancreatic disease. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 3-19. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; SMAD4 (DPC4); PANCREAS; CANCER DE PANCREAS; METASTASE


800/1272US=84-A / Biol/Mol
Weber SM, Lu SL, Bernstein S, Wang XJ. Transformig growth factor-B in developing and advanced cancers: role of transforming growth factor-B in the pathogenesis of human head and neck squamous cell carcinoma. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 21-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FACTOR DE CRESCIMENTO TRANSFORMANTE-B; CARCINOMA DE CELULAS ESCAMOSAS. CABECA E PESCOCO; TRANSGENICA RATO; RATO KNOCKOUT


Primeira | Anterior | Próxima | Última